Med X Health
Podcast by MedX Health
Rajoitettu tarjous
2 kuukautta hintaan 1 €
Sitten 7,99 € / kuukausiPeru milloin tahansa.
Arvioitu 4.7 App Storessa
Lisää Med X Health
This podcast discusses MedX Health, listed on the TSX-V under the symbol MDX, whose mission is to develop and implement non-invasive, practical, drug-free and cost-effective skin analysis and assessment systems for use by trained medical professionals, as well as light therapeutics and imaging systems that can help to save lives and enhance patients’ quality of life and improve standards of care.
Kaikki jaksot
3 jaksot
MedX Health Corp. (TSX-V: MDX) Full webcast at the SNN Network Canada Virtual Event on January 6-7, 2021. For more information about MedX Health Corp., please visit: https://medxhealth.com/ [https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqblpNZnRVb0J0VkhxemJ3TG5VMDRiWWJFU19ad3xBQ3Jtc0tuVWdKeEtsdUcyR2dXbFg2eU5GdXZCa2owLUc2SFNMSkRQeG5EVTFOSWJUamNzb1BrQVRJX0tVdVp4Y0FwazRTbFBqMVM1UHQzQnNrLVVDWG9fLVNuZmNSbmJuZUJyT1pjeHhYUi1DUXRsanB6UENmRQ&q=https%3A%2F%2Fmedxhealth.com%2F] The interview may contain forward looking statements about MedX Health Corp. See MedX Health Corp.'s periodic filings with SEDAR for more complete information.
“MedX has put together a platform that allows us to do early detection of skin cancer…Everything has been completed in terms of the scalability and interest in the market for our technology. That is what we are doing right now.” States Mike Druhan, Vice President Corporate Development atMedX Health Corp. [https://investorintel.com/iintel-members/medx-health-corp/] (TSXV: MDX), in an interview with InvestorIntel Corp. CEO Tracy Weslosky.
MedX Health Prototyping in the Medical Industry
Arvioitu 4.7 App Storessa
Rajoitettu tarjous
2 kuukautta hintaan 1 €
Sitten 7,99 € / kuukausiPeru milloin tahansa.
Podimon podcastit
Mainoksista vapaa
Maksuttomat podcastit
